{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:14:20Z","timestamp":1765610060900,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ymgmr.2020.100646","type":"journal-article","created":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T13:29:18Z","timestamp":1599485358000},"page":"100646","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Clinical outcomes in an adult patient with mannose phosphate isomerase-congenital disorder of glycosylation who discontinued mannose therapy"],"prefix":"10.1016","volume":"25","author":[{"given":"Kinza","family":"Noman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian J.","family":"Hendriksz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham","family":"Radcliffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Roncaroli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sulleman","family":"Moreea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afifah","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina M.","family":"Stepien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2020.100646_bb0005","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.bbadis.2008.11.012","article-title":"The clinical spectrum of phosphomannose isomerase deficiency, with an evaluation of mannose treatment for CDG Ib","volume":"1792","author":"De Lonlay","year":"2009","journal-title":"Biochim. Biophis. Acta."},{"issue":"Suppl. 3","key":"10.1016\/j.ymgmr.2020.100646_bb0010","first-page":"S487","article-title":"Seizures and stupor during intravenous mannose therapy in a patient with CDG syndrome type Ib (MPI-CDG)","author":"Schroder","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2020.100646_bb0015","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1651-2227.2002.tb00101.x","article-title":"Oral mannose therapy persistently corrects the severe clinical symptoms and biochemical abnormalities of phosphomannose isomerase deficiency","volume":"91","author":"Harms","year":"2002","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgmr.2020.100646_bb0020","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1172\/JCI2350","article-title":"Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy","volume":"101","author":"Niehues","year":"1998","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.ymgmr.2020.100646_bb0025","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bbrc.2014.06.021","article-title":"Mannose metabolism: more than meets the eye","volume":"453","author":"Sharma","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgmr.2020.100646_bb0030","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/1098-1004(200009)16:3<247::AID-HUMU7>3.0.CO;2-A","article-title":"Genomic organisation of the human phosphomannose isomerase (MPI) gene and mutation analysis in patients with congenital disorders of glycosylation type Ib (CDGIb)","volume":"16","author":"Schollen","year":"2000","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgmr.2020.100646_bb0035","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/adc.85.4.339","article-title":"Successful treatment of carbohydrate deficient glycoprotein syndrome type Ib with oral mannose","volume":"85","author":"Hendriksz","year":"2001","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymgmr.2020.100646_bb0040","first-page":"379","article-title":"Hyperinsulinemic hypoglycaemia as a presenting sign in phosphomannose isomerase deficiency: a new manifestation of carbohydrate-deficient glycoprotein syndrome treatable with mannose","volume":"135","author":"De Lonlay","year":"1999","journal-title":"J. Paediatr. Dent."},{"key":"10.1016\/j.ymgmr.2020.100646_bb0045","first-page":"368","article-title":"A 20-years follow-up of a case of congenital disorder of glycosylation type Ib","volume":"5","author":"Stepien","year":"2017","journal-title":"J. Inborn. Errors. Metab. Screen."},{"key":"10.1016\/j.ymgmr.2020.100646_bb0050","first-page":"1","article-title":"J, et al, consensus guideline for the diagnosis and management of mannose phosphate isomerase-congenital disorder of glycosylation","author":"Cechova","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgmr.2020.100646_bb0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/mgme.2001.3161","article-title":"Genetic and metabolic analysis of the first adult with congenital disorder of glycosylation type Ib: long-term outcome and effects of mannose supplementation","volume":"73","author":"Westphal","year":"2001","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgmr.2020.100646_bb0060","first-page":"379","article-title":"MPI-CDG with transient hypoglycosylation and antithrombin deficiency","volume":"104","author":"De la Morena-Barrio","year":"2019","journal-title":"Haematological"},{"key":"10.1016\/j.ymgmr.2020.100646_bb0065","first-page":"1020","article-title":"Initial results of mannose therapy in N-glycosylation disorders","volume":"7","author":"Freeze","year":"1997","journal-title":"Glycobiology"},{"key":"10.1016\/j.ymgmr.2020.100646_bb0070","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1542\/peds.2013-2732","article-title":"Successful liver transplantation and long term follow-up in a patient with MPI-CDG","volume":"134","author":"Janssen","year":"2014","journal-title":"Pediatrics."},{"key":"10.1016\/j.ymgmr.2020.100646_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19051304","article-title":"CDG therapies: from bench to bedside","volume":"19","author":"Brasil","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgmr.2020.100646_bb0080","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cca.2014.01.018","article-title":"Asymptomatic phosphomannose isomerase deficiency (MPI-CDG) initially mistaken for excessive alcohol consumption","volume":"431","author":"Helander","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgmr.2020.100646_bb0085","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2018.10.45","article-title":"Congenital disorders of glycosylation","volume":"6","author":"Chang","year":"2018","journal-title":"Ann. Transl. Med."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426920300926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426920300926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:51:35Z","timestamp":1762001495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426920300926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":17,"alternative-id":["S2214426920300926"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2020.100646","relation":{},"ISSN":["2214-4269"],"issn-type":[{"type":"print","value":"2214-4269"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcomes in an adult patient with mannose phosphate isomerase-congenital disorder of glycosylation who discontinued mannose therapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2020.100646","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100646"}}